Introducing Medical Grade CBD Topical Cream


Canadian Licensed Cannabis Producer MedReleaf Continues To Set The Medical Grade Standard Within The Cannabis Industry


MedReleaf has introduced a topical cream to the Canadian market, specifically formulated to provide optimal absorption with their award-winning CBD oils. This uniquely formulated product was developed in response to feedback from patients who were looking for a CBD topical application. In response, MedReleaf has delivered a high-absorption topical cream, optimal for mixing with their CBD oils. CBD or Cannabidiol has been reported to help with symptoms such as:

  • pain

  • inflammation

  • skin problems

  • sports injuries

  • headaches/migraines


“The dermatology community is very intrigued and excited about the potential benefits of cannabinoids including Cannabidiol (CBD),” explains Dr. Jaggi Rao, MD, Board Certified Dermatologist, and Clinical Professor of Medicine at the University of Alberta. “They have already demonstrated anti-inflammatory benefits in muscle and joint disorders, and the translation of this success to skin diseases is only logical.”

The facts and findings make the introduction of a high absorption cream designed to optimize mixing with CBD oil is not only exciting but timely. CBD topicals are experiencing tremendous popularity and strong growth in US markets due to research that has proven that CBD topicals effectively provide relief to patients suffering from eczema, acne, impetigo and various other common skin conditions, but without the common (and often nasty) adverse side effects of conventional prescriptions and over-the-counter medications.




The Health Canada approved topical cream was scientifically engineered to specifically work with MedReleaf CBD oils, Midnight or Avidekel, and was formulated using cosmetic grade ingredients to create an easy-to-use topical agent for direct application. “We agree with the dermatological community that this is an exciting breakthrough when it comes to treating some common skin conditions,” notes Neil Closner, CEO of MedReleaf. “Our product development team has devised a method to provide Canadian patients with a much sought-after, high-absorption, topical cream that is within the strict limitations afforded by the current regulations.”




Included with the purchase of MedReleaf’s topical cream are easy-to-follow instructions that detail how to mix the cannabis oil into the topical cream. When you consider the CBD content from the suggested volume (8 mL) of Avidekel CBD oil, a patient is now able to create a high-absorption CBD topical that has substantially more CBD than similar products currently on the market in the United States.


MedReleaf Topical Cream is now available at a special introductory price to allow as many patients as possible to experience this exciting new product. You can visit for more details.

November 12, 2017

by Parker Wallace

Profile photo of Parker Wallace
Parker is a cannabis enthusiast to the core who shares a keen interest in listening to what others have to say and understanding what’s important to them. Those who know Parker know that his passion for health and wellness runs deep, and his love of Canada even deeper!


The Latest In Cannabis Technology & Innovation
Using Weed To Spark Creativity In The Workplace
It’s Time To Free Marijuana And Regulate Sugar
Know Thy Grower
Cannabis In The U.S Workplace
Former NFL Star Ricky Williams Launches Cannabis Brand
Global Cannabis Exports
Produce & Flower Greenhouses Converting To Cannabis
Post-Surgery Recovery Using Cannabis
Microdosing Away Depression
2018 Benchmark Cannabis Research Studies
The Connection Between Cannabis And Nausea
Cannabis Infused Booze-Free Beer
2018 Global Cannabis Price Index
Hemp Oil Vs. CBD Oil
Why The Love And Hate For Blunts?